FDA Inspection
Hisamitsu Pharmaceutical Co., Inc.Hisamitsu Pharmaceutical Co., Inc. – FDA Inspection, Sep 15, 2017
Record Details
This FDA Inspection record concerns Hisamitsu Pharmaceutical Co., Inc., with an inspection on September 15, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Milva E. Melendez Perales (Issuing Officer)
View Company Profile
ID · e98c2f04-cea3-45e3-9a2f-c93708e5ade3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1025424
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.188Prepared for each batch, include complete information
- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.46(b)Equipment for Environmental Control
- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hisamitsu Pharmaceutical Co., Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 4, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
| May 31, 2019 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| April 11, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 17, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 1, 2009 | NAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
Other documents for Hisamitsu Pharmaceutical Co., Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.